APR 19, 2020 10:56 PM PDT

Large Molecule Database Can Aid in Drug Discovery

WRITTEN BY: Nouran Amin

Scientists have recently developed a large molecule database that can help drug development. The database called ‘MacrolactoneDB’ is a collection of 14,000 macrolactones -- large molecules used in drug discovery that contain information on molecular characteristics, chemical diversity and biological activity.

Macrolactones are ring-like structures made of at least 12 atoms. They hold an ability to behind to difficult protein targets which make the useful as the basis for antiviral, antibiotic, antifungal and antiparasitic drugs. Even though they can be used as a weapon against infections, they are challenged by their size and complicated structure that make it difficult for synthesizing.

"Macrolactones are titanic molecules -- their size presents challenges to researchers who may want to work with them," says Sean Ekins, CEO of Collaborations Pharmaceuticals, member of NC State's Comparative Medicine Institute, entrepreneur in residence at UNC-Chapel Hill's Eshelman School of Pharmacy and corresponding author of the research. "We wanted to address that issue by creating a publicly available database of these molecules and their properties."

Out of the 14,000 macrolactones compiled into the MacrolactoneDB--only 20% of them have biological data. To better characterize the molecules, researchers conducted cheminformatics analyses of the macrolactone molecular properties developing 91 descriptors. In addition, they used machine-learning to look at three targets of interest specifically malaria, hepatitis C and T cells and characterize their relationship with the macrolactone.

Learn more:

"Anyone interested in these molecules or in drug development utilizing macrolactones now has a user-friendly database where everything is accessible and in one location," Ekins says. "Researchers can ask questions about what makes a particular macrolactone molecule well-suited for a particular biological application.

"Hopefully MacrolactoneDB will help us to understand this diverse class of molecules, and move forward in creating new ones."

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 08, 2020
Drug Discovery & Development
APR 08, 2020
Does Tuberculosis Vaccine Really Defend from COVID-19?
The spread of COVID-19 has panned out very differently in different countries. While in some such as the US, the UK and ...
APR 11, 2020
Cancer
APR 11, 2020
The Mice Make the Difference in CAR-T Studies
It is quite common in cancer therapies to see a drug or treatment that has been around for decades. New drugs are hard t ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Combination Immunotherapy Allows Immune Cells To Target Tumors
A drug combination of immunotherapeutic agents encourages immune cells to devour cancer cells according to findings publ ...
MAY 06, 2020
Cancer
MAY 06, 2020
Olanzapine useful for cancer patients managing nausea unrelated to chemo
A study published last week in JAMA Oncology reports that a generic drug called Olanzapine could be useful for cancer pa ...
MAY 16, 2020
Cannabis Sciences
MAY 16, 2020
Body's Own Cannabis Helps Us Forget Traumatic Events
Researchers have found that anandamide, often referred to as the body’s own cannabis, may help us forget traumatic ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
Drug Targets Off Episodes of Parkinson
A novel drug was approved by the FDA to target the “off” episodes of Parkinson disease. The drug is referred ...
Loading Comments...